Latest Earnings Results: Q2 '26
Estimated EPS
$2.74
Reported EPS
$3.02
Surprise
+10.14%
Estimated Rev
$977.2M
Reported Rev
$1B
Surprise
+2.75%
• Reported GAAP EPS of -$0.03 down -102.83% YoY • Reported revenue of $1B down -2.72% YoY • Charles River Laboratories is increasing its 2026 revenue and non-GAAP earnings per share guidance, reflecting operational outperformance, while reducing GAAP earnings per share guidance due to net loss from divestitures.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $2.96 | -- | -- | N/A |
Q2 '26 | $2.74 | $3.02 | 10.14% | BEAT |
Q1 '26 | $1.94 | $2.06 | 6.00% | BEAT |
Q4 '25 | $2.34 | $2.39 | 1.98% | BEAT |
Q3 '25 | $2.34 | $2.43 | 3.95% | BEAT |